Price chart
Loading 1Y daily…
Financial overlay · last 12 quarters
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $273.2B | $3.3B | $7.1B | $0.9B | 1.2% | 2.6% |
| 2025-12-31 | $72.4B | $1.2B | $nanB | $5.8B | 1.7% | nan% |
| 2025-09-30 | $69.5B | $1.9B | $2.3B | $3.1B | 2.7% | 3.4% |
| 2025-06-30 | $66.9B | $1.5B | $2.1B | $-2.2B | 2.3% | 3.1% |
| 2025-03-31 | $65.5B | $1.3B | $1.7B | $1.6B | 2.0% | 2.6% |
| 2024-12-31 | $nanB | $nanB | $1.9B | $nanB | nan% | nan% |
Earnings replay · last 20 reports
| Date | EPS actual | EPS est | Surprise |
|---|---|---|---|
| 2026-04-30 | 7.79 | 7.61 | +2.4% |
| 2026-02-05 | 8.08 | 7.88 | +2.5% |
| 2025-10-30 | 7.83 | 7.64 | +2.5% |
| 2025-07-31 | 7.20 | 7.15 | +0.7% |
| 2025-05-02 | 6.74 | 6.35 | +6.2% |
| 2025-01-30 | 6.64 | 7.82 | -15.1% |
| 2024-10-31 | 7.51 | 7.25 | +3.5% |
| 2024-08-01 | 6.72 | 6.42 | +4.7% |
| 2024-05-02 | 6.47 | 6.22 | +4.0% |
| 2024-02-02 | 6.79 | 6.54 | +3.8% |
| 2023-11-02 | 6.77 | 6.68 | +1.4% |
| 2023-08-03 | 6.13 | 6.04 | +1.6% |
| 2023-05-05 | 5.41 | 5.24 | +3.3% |
| 2023-02-03 | 4.96 | 4.87 | +1.9% |
| 2022-11-03 | 6.04 | 5.71 | +5.7% |
| 2022-08-04 | 6.22 | 5.49 | +13.2% |
| 2022-05-06 | 6.01 | 5.18 | +16.1% |
| 2022-02-03 | 4.77 | 4.71 | +1.2% |
| 2021-11-04 | 5.73 | 5.21 | +10.1% |
| 2021-08-05 | 5.24 | 4.97 | +5.5% |
Earnings markers are overlaid on the price chart above. Transcript summaries require PERPLEXITY_API_KEY (deferred to a follow-up).
Peer comparison · Healthcare
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| CI ★ | $73B | 2.4 | 8.2 | 0.3 | 7.1 | 1.7 | 9.1% | 4.6% | 29.1% | 9.54% |
| LLY | $970B | 38.6 | 24.5 | 13.4 | 27.3 | 31.1 | 82.8% | 55.5% | 169.9% | 0.94% |
| UNH | $350B | 29.1 | 18.5 | 0.8 | 18.5 | 3.6 | 18.8% | 2.0% | 0.7% | 5.05% |
| JNJ | $539B | 26.0 | 17.6 | 5.6 | 16.6 | 6.6 | 68.0% | 9.9% | -52.9% | 2.32% |
| MRK | $286B | 32.6 | 12.1 | 4.3 | 11.2 | 6.2 | 76.7% | 4.9% | — | 4.92% |
| ABBV | $387B | 106.7 | 13.5 | 6.2 | 14.8 | -58.1 | 72.0% | 12.4% | -46.2% | 5.38% |
| PFE | $145B | 19.5 | 9.0 | 2.3 | 7.8 | 1.6 | 74.8% | 5.4% | -10.1% | 8.51% |
| TMO | $175B | 26.0 | 17.3 | 3.9 | 19.4 | 3.3 | 40.9% | 6.2% | 11.3% | 3.15% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Top institutional holders
Top-10 concentration: 43.37%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 22,598,152 | 8.54% |
| Vanguard Capital Management LLC | 17,122,069 | 6.47% |
| State Street Corporation | 12,283,141 | 4.64% |
| Massachusetts Financial Services Co. | 11,595,182 | 4.38% |
| Dodge & Cox Inc. | 11,555,787 | 4.37% |
| FMR, LLC | 10,957,272 | 4.14% |
| Sanders Capital, LLC | 10,290,382 | 3.89% |
| Geode Capital Management, LLC | 6,200,342 | 2.34% |
| Vanguard Portfolio Management LLC | 6,163,438 | 2.33% |
| GQG Partners LLC | 6,002,448 | 2.27% |
Insider activity · 90d
No insider trades for CI in last 90d.
Analyst estimates
yfinanceConsensus: buy (mean 1.54167). Distribution requires FINNHUB_API_KEY.
SEC filings
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-06-02 | FORM 4 | view · |
| 4 | 2026-05-14 | FORM 4 | view · |
| 8-K | 2026-05-13 | 8-K | view · |
| 10-Q | 2026-04-30 | 10-Q | view · |
| 8-K | 2026-04-30 | 8-K | view · |
| 8-K | 2026-04-27 | 8-K | view · |
| 4 | 2026-04-24 | FORM 4 | view · |
| 4 | 2026-04-24 | FORM 4 | view · |
| 4 | 2026-04-24 | FORM 4 | view · |
| 4 | 2026-04-24 | FORM 4 | view · |
| 4 | 2026-04-24 | FORM 4 | view · |
| 4 | 2026-04-24 | FORM 4 | view · |
| 4 | 2026-04-24 | FORM 4 | view · |
| 4 | 2026-04-24 | FORM 4 | view · |
| 4 | 2026-04-24 | FORM 4 | view · |
| 4 | 2026-04-24 | FORM 4 | view · |
| DEF 14A | 2026-03-13 | DEF 14A | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 8-K | 2026-03-03 | 8-K | view · |
| 8-K | 2026-02-27 | 8-K | view · |
| 10-K | 2026-02-26 | 10-K | view · |
| 8-K | 2026-02-05 | 8-K | view · |
| 4 | 2025-12-02 | FORM 4 | view · |
| 8-K | 2025-11-18 | 8-K | view · |
| 4 | 2025-11-03 | FORM 4 | view · |
| 10-Q | 2025-10-30 | 10-Q | view · |
| 8-K | 2025-10-30 | 8-K | view · |
| 8-K | 2025-10-20 | 8-K | view · |
| 4 | 2025-10-07 | FORM 4 | view · |
| 8-K | 2025-09-04 | 8-K | view · |
| 4 | 2025-09-03 | Insider transaction (Form 4) | view · |
| 4 | 2025-09-03 | Insider transaction (Form 4) | view · |
| 8-K | 2025-09-02 | 8-K | view · |
| 4 | 2025-08-19 | Insider transaction (Form 4) | view · |
| 10-Q | 2025-07-31 | 10-Q | view · |
| 8-K | 2025-07-31 | 8-K | view · |
| 4 | 2025-06-04 | Insider transaction (Form 4) | view · |
| 4 | 2025-06-03 | Insider transaction (Form 4) | view · |
| 8-K | 2025-06-02 | 8-K | view · |
| 8-K | 2025-05-20 | 8-K | view · |
| 10-Q | 2025-05-02 | 10-Q | view · |
| 8-K | 2025-05-02 | 8-K | view · |
| 8-K | 2025-04-28 | 8-K | view · |
| 4 | 2025-04-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-04-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-04-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-04-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-04-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-04-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-04-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-04-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-04-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-04-25 | Insider transaction (Form 4) | view · |
About
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, an…